← Open Payments lookup

LILIA SANTAMARIA-CANO: Open Payments

NPI 1841670528 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,507 in 75 payments from 16 companies in 2025. Trend: 2023 $1,366 · 2024 $1,844 · 2025 $1,507

Food & beverage: $1,507
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$259
GlaxoSmithKline, LLC.12$208
ABBVIE INC.13$200
Lilly USA, LLC12$156
Astellas Pharma US Inc4$128
Corcept Therapeutics4$106
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$105
Abbott Laboratories3$72
Novo Nordisk Inc3$65
Bayer Healthcare Pharmaceuticals Inc.3$57

Products named: TRELEGY ELLIPTA, FARXIGA, UBRELVY, Veozah, MOUNJARO, Korlym, XIFAXAN, FREESTYLE LIBRE 3.

Industry payments across AZ — which companies pay providers there.